Management ChangeMay 21, 2026, 06:46 AM
Rentokil Initial Appoints Rafael Carrasco as CEO, North America
AI Summary
Rentokil Initial plc announced the appointment of Rafael "Rafa" Carrasco as Chief Executive Officer, North America, commencing August 3, 2026. Carrasco brings a distinguished track record from large-scale, route-based service industries, having most recently served as President of WM Healthcare Solutions and Senior Vice President of Strategy at WM. The company highlighted his expertise in operational leadership, strategic transformation, and integration of major acquisitions. Alain Moffroid, the current interim CEO, North America, will support Carrasco and the team through the end of 2027 to ensure a smooth transition.
Key Highlights
- Rentokil Initial appointed Rafael "Rafa" Carrasco as Chief Executive Officer, North America, effective August 3, 2026.
- Carrasco previously served as President of WM Healthcare Solutions and Senior Vice President of Strategy at WM.
- He oversaw multi-site operations with over 200 branches and 10,000+ employees across the U.S., Canada, U.K., Ireland, and Western Europe.
- Carrasco has extensive experience in operational leadership, strategic transformation, and executing recurring revenue models.
- He led the integration of Stericycle, a $7.2 billion acquisition, achieving standout first-year cost synergies.
- Alain Moffroid, the current interim CEO, North America, will remain on the NA leadership group to support the transition through the end of 2027.
Price Impact
More from RTO